2025. CAR T-Cell Therapy Outcomes and Toxicity Profiles in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. Annals of Leukemia Research. 6, 1 (Aug. 2025), 10–15. DOI:https://doi.org/10.5281/zenodo.22238163.